Table 1.
Demographic characteristics of all hospitalized patients with COVID-19 included in this study (N=4029)a.
| Characteristic | Mount Sinai Brooklyn | Mount Sinai Hospital | Mount Sinai Morningside | Mount Sinai Queens | Mount Sinai West | P value | |
| Number of patients, n | 611 | 1644 | 749 | 540 | 485 | —b | |
| Gender, n (%) | |||||||
| Male | 338 (55.3) | 951 (57.8) | 411 (54.9) | 344 (63.7) | 257 (53.0) | .004 | |
| Female | 273 (44.7) | 693 (42.2) | 338 (45.1) | 196 (36.3) | 228 (47.0) | .004 | |
| Age (years), median (IQR) | 72.5 (63.6-82.7) | 63.3 (51.3-73.2) | 69.8 (57.4-80.3) | 68.1 (57.1-78.8) | 66.3 (52.5-77.6) | <.001 | |
| Ethnicity, n (%) | |||||||
| Hispanic | 21 (3.4) | 460 (28.0) | 259 (34.6) | 198 (36.7) | 111 (22.9) | <.001 | |
| Non-Hispanic | 416 (68.1) | 892 (54.3) | 452 (60.3) | 287 (53.1) | 349 (72.0) | <.001 | |
| Unknown | 174 (28.5) | 292 (17.8) | 38 (5.1) | 55 (10.2) | 25 (5.2) | <.001 | |
| Race, n (%) | |||||||
| Asian | 13 (2.1) | 83 (5.0) | 16 (2.1) | 56 (10.4) | 27 (5.6) | <.001 | |
| Black/African American | 323 (52.9) | 388 (23.6) | 266 (35.5) | 64 (11.9) | 109 (22.5) | <.001 | |
| Other | 54 (8.8) | 705 (42.9) | 343 (45.8) | 288 (53.3) | 164 (33.8) | <.001 | |
| Unknown | 27 (4.4) | 87 (5.3) | 25 (3.3) | 14 (2.6) | 14 (2.9) | <.001 | |
| White | 194 (31.8) | 381 (23.2) | 99 (13.2) | 118 (21.9) | 171 (35.3) | <.001 | |
| Past medical history, n (%) | |||||||
| Acute myocardial infarction | 14 (2.3) | 16 (1.0) | — | 15 (2.8) | 7 (1.4) | .006 | |
| Acute respiratory distress syndrome | — | 28 (1.7) | — | — | — | <.001 | |
| Acute venous thromboembolism | — | 11 (0.7) | — | — | — | .74 | |
| Asthma | — | 100 (6.1) | 39 (5.2) | 19 (3.5) | 27 (5.6) | <.001 | |
| Atrial fibrillation | 23 (3.8) | 113 (6.9) | 44 (5.9) | 49 (9.1) | 28 (5.8) | .005 | |
| Cancer | 22 (3.6) | 190 (11.6) | 47 (6.3) | 21 (3.9) | 41 (8.5) | <.001 | |
| Chronic kidney disease | 46 (7.5) | 208 (12.7) | 75 (10.0) | 81 (15.0) | 33 (6.8) | <.001 | |
| Chronic obstructive pulmonary disease | 11 (1.8) | 64 (3.9) | 31 (4.1) | 28 (5.2) | 19 (3.9) | .04 | |
| Chronic viral hepatitis | — | 17 (1.0) | 14 (1.9) | — | — | .02 | |
| Coronary artery disease | 56 (9.2) | 168 (10.2) | 92 (12.3) | 82 (15.2) | 51 (10.5) | .008 | |
| Diabetes mellitus | 93 (15.2) | 351 (21.4) | 165 (22.0) | 154 (28.5) | 76 (15.7) | <.001 | |
| Heart failure | 36 (5.9) | 110 (6.7) | 61 (8.1) | 43 (8.0) | 30 (6.2) | .38 | |
| Human immunodeficiency virus | — | 32 (1.9) | 11 (1.5) | — | 14 (2.9) | .001 | |
| Hypertension | 112 (18.3) | 549 (33.4) | 249 (33.2) | 225 (41.7) | 139 (28.7) | <.001 | |
| Intracerebral hemorrhage | — | — | — | — | — | .24 | |
| Liver disease | — | 53 (3.2) | 15 (2.0) | 15 (2.8) | — | <.001 | |
| Obesity | — | 176 (10.7) | 74 (9.9) | 38 (7.0) | 29 (6.0) | <.001 | |
| Obstructive sleep apnea | — | 54 (3.3) | 15 (2.0) | — | — | <.001 | |
| Stroke | — | 24 (1.5) | — | — | — | .054 | |
| Mortality within 7 days, n (%) | 148 (24.2) | 118 (7.2) | 93 (12.4) | 124 (23.0) | 27 (5.6) | <.001 | |
aInterhospital comparisons for categorical data were assessed with Chi-square tests. Numerical data were assessed with Kruskal-Wallis tests, and Bonferroni-adjusted P values were reported. Values relating to <10 patients per field were not provided to protect patient privacy (--).
bNot available.